Betagenon AB ^Investor

Biotechnology companyВідповідно до джерел: 2Betagenon is a biotechnology company focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat chronic energy balance disorders diseases in metabolically challenged elderly and/or obese AB - AB operates as a biotechnology company. The Company develops novel, safe, and effective therapies for treatment of obesity-related disorders including type 2 diabetes, fatty liver, disorders linked to hyperinsulinemia, and various forms of AB - Company …